Psorinum (Energique, Inc.)
Welcome to the PulseAid listing for the Psorinum drug offered from Energique, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Energique, Inc. |
| NON-PROPRIETARY NAME: | Psorinum |
| SUBSTANCE NAME: | SCABIES LESION LYSATE (HUMAN) |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | LIQUID |
| MARKETING CATEGORY NAME: | UNAPPROVED HOMEOPATHIC |
| START MARKETING DATE: | 2014-12-09 |
| END MARKETING DATE: | 0000-00-00 |
Psorinum HUMAN PRESCRIPTION DRUG Details:
| Item Description | Psorinum from Energique, Inc. |
| LABELER NAME: | Energique, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 7([hp_X]/mL) |
| START MARKETING DATE: | 2014-12-09 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 44911-0097_fde517ab-34b1-407d-b8aa-fcd65b8d1607 |
| PRODUCT NDC: | 44911-0097 |
| APPLICATION NUMBER: | |
Other SCABIES LESION LYSATE (HUMAN) Pharmaceutical Manufacturers / Labelers:
